Increased risk of disseminated cryptococcal infection in a patient with multiple sclerosis on fingolimod
Multiple sclerosis (MS) is the most common autoimmune disease of the central nervous system (CNS), with an estimated 2.3 million people being affected globally, and is a major cause of permanent disability. About 90 % of the affected patients with MS have relapsing-remitting type. Fingolimod became...
Main Authors: | Pushpinder Kaur, Alana Lewis, Abdul Basit, Nikolas St Cyr, Zaman Muhammad |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | IDCases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250920302699 |
Similar Items
-
Acute Disseminated Encephalomyelitis
by: J Gordon Millichap
Published: (2005-12-01) -
Disseminated herpes zoster in the course of chronic myeloid leukemia
by: Dorota Artyszuk, et al.
Published: (2021-08-01) -
Disseminated herpes zoster misdiagnosed as orbital complication of acute sinusitis
by: Joong Su Park, et al.
Published: (2020-11-01) -
Effect of fingolimod on platelet count among multiple sclerosis patients
by: Mehrdad Farrokhi, et al.
Published: (2015-01-01) -
Disseminated cutaneous cryptococcal infection in kidney transplant recipient
by: Suhas Dilip Mondhe, et al.
Published: (2019-01-01)